Skip to main content

Optimapharm announces the acquisition of CTG (Clinical Trials Group)

By April 13, 2022June 27th, 2022No Comments

Optimapharm announces the acquisition of CTG (Clinical Trials Group)

We Deliver on
Your Promises

Optimapharm d.o.o. (“Optimapharm”), a leading European, mid-sized, full-service Clinical Research Organization (CRO), is pleased to announce the acquisition of CTG (Clinical Trials Group). This acquisition will complement Optimapharm’s geographic coverage and significantly strengthen Optimapharm’s presence in Eastern Europe. With the acquisition of CTG, Optimapharm expands its operational team, providing best-inclass, tailor-made clinical research solutions to Biotech, Pharma, and Medical Device clients worldwide.

Optimapharm is a full-service CRO that manages clinical trials across Europe and currently conducts more than 300 trials in 36 countries. The company was founded in 2006 in Zagreb and today operates through 24 offices in strategic locations in Europe and conducts operational activities in 12 additional European countries and Israel. Optimapharm conducts phase I – IV studies in all therapeutic areas with a specific focus on Oncology, Neurosciences, Cardiology, Endocrinology, and Infectious diseases. The company possesses indepth expertise and long-lasting experience combined with a flexible and collaborative approach to tailor the services to each individual study.

CTG was established in 1998, headquartered in Bucharest, Romania, and brings over 20 years of experience in managing projects across all phases of clinical development. The CTG team consists of more than 40 highly experienced employees located in Romania, Bulgaria, Serbia, Moldova, and Bosnia-Herzegovina. Currently, CTG is also operating in Poland, Hungary, Croatia and Slovakia through a network of partners. CTG has strong expertise in managing Haemato-oncology, Neurosciences, and Cardiology trials coming from global Pharma and Biotech companies, providing services focused on Project Management, Clinical Monitoring, and Regulatory & Ethics Committee submission and management.

Optimapharm reinforces its position as a mid-sized European CRO market leader by acquiring CTG, and its geographical presence extends with additional offices located in Romania and Moldova. The Optimapharm organization now consists of over 440 employees dedicated to providing service and expertise that delivers high-quality, cost-effective results, including deep local expertise across Europe.

“We are pleased to welcome CTG to the Optimapharm organization, and we are very proud of the growth that the Optimapharm team has achieved in recent months. We are expanding our operational capabilities and our geographic footprint in Eastern Europe with a focus on the territory of Romania and Moldova. The CTG organization is an excellent complement to Optimapharm. We share the same business approach of delivering customized, supreme solutions for our clients and we are looking forward to working with CTG’s dynamic group of clients developing unique therapies for unmet medical needs” said Dr. Gordana Gregurić Čičak, Chief Operating Officer of Optimapharm.

About Optimapharm
Founded in 2006 in Croatia, Optimapharm is a leading, full-service, contract research organization (“CRO”) managing clinical trials on behalf of the global biopharmaceutical and medical device companies. Optimapharm offers unrivaled access to patients and Investigators, covering markets with a total population of over 500 million people. Optimapharm conducts studies in all phases of clinical development and all therapeutic areas. The Company is also a leading CRO for Medical Device companies and has a reputation for excellence in rescuing studies. Optimapharm’s key differentiators are its track record of delivery excellence, committed and stable project teams, access to patients in the emerging markets of Eastern and Central Europe, coupled with our strong presence in the more established markets of Western Europe, and a customer-focused approach. These differentiators enable Optimapharm to offer a highly cost-effective clinical development solution. We Deliver on Your Promises. Web site:

About CTG (Clinical Trials Group)
CTG (Clinical Trials Group) is a regional CRO emphasizing activities in Central & South-Eastern Europe, currently managing clinical trials in 10 countries. Starting back in 1998 in Romania, CTG has successfully run more than 70 clinical trials and non-interventional studies to date, with more than 7000 patients enrolled and more than 1000 centers involved. Our clients are global pharma, biotech, medical device companies, contract research organizations, and international medical organizations. We strive to establish a partnership with our clients based on integrity and trust to provide the highest quality of services. The key to our success and achievements in medical research comes from understanding our clients’ needs, with particular attention and flexibility for all details towards achieving the client’s goals, with a WorldWISE and local combined approach. Our mission toward our customers is to deliver outstanding value through personalized services at the highest professional standards. Web site:

“I wanted to say thank you for your superb support and collaboration this year. I am looking forward to work with you in 2019 as it is a pleasure to work with you and your team.”

Senior Manager Partner

Let’s talk about your pharma study needs